News

  • 15 June 2018

    Johnson & Johnson sells LifeScan to Platinum Equity

    Global pharmaceutical company Johnson & Johnson has accepted investment firm Plantinum Equity’s offer to acquire LifeScan, its blood glucose monitoring business, for approximately $2.1bn.